Delivery Order SPE2DB24D1021-SPE2DB25FEUNY
Award Date 3/5/25
Potential Completion Date 3/6/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TECFIDERA DR 240 MG CAPSULE UU 60S. The $8,789.23 firm fixed price contract has an ultimate completion date of October 23, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $82,328.05 delivery order contract is for the supply of Tecfidera (dimethyl fumarate) 240 mg capsules to support military healthcare programs. The contract has a completion date of November 24, 2021 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Tecfidera 240 mg capsules. The $40,728.86 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,744.57 firm-fixed-price delivery order is for the supply of Tecfidera, a prescription medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, including Tecfidera (dimethyl fumarate) capsules. The $98,367.67 firm fixed-price delivery order has an ultimate completion date of October 20, 2016. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $146,705.11 firm fixed price delivery order is for the supply of the pharmaceutical product TECFIDERA DR 240MG 60S. No set-aside designation was used. AmerisourceBergen Drug Corp has an existing indefinite delivery contract with the Department of Justice Federal Bureau of Investigation (FBI) Headquarters Division to...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $21,261.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- The Defense Logistics Agency awarded a $4,428.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Tecfidera (dimethyl fumarate) 240 mg capsules in quantities of 60 units. This is a non-set-aside contract with performance completion targeted for September 19, 2025, and fulfillment occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- This federal contract award, valued at $84,081.21, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,644.98, is a delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEUNYDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,333.39, is a delivery order for TECFIDERA DR 240 MG CAPSULE UU 60S, a pharmaceutical product. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 7/1/25, 8:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 3/5/25 |